Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lars Bauer

Showing results (1-10 of 47) with videos related to

Pageof 5
Sort By:
BMC Neurology|September 27, 2012
Transdermal rotigotine for the perioperative management of restless legs syndromeBirgit Högl, Wolfgang H Oertel, Erwin Schollmayer, et al.
Journal of Parkinson'S Disease|April 11, 2016
Rotigotine in Combination with the MAO-B Inhibitor Selegiline in Early Parkinson's Disease: A Post Hoc AnalysisNir Giladi, Mahnaz Asgharnejad, Lars Bauer, et al.
Studies in Health Technology and Informatics|October 2, 2004
Realtime textured 3D-models for medical applicationsCarsten Kübler, Lars Bauer, Peter Heinze, et al.
Expert Opinion on Pharmacotherapy|June 21, 2016
Evaluation of rotigotine transdermal patch for the treatment of depressive symptoms in patients with Parkinson's diseaseSun Ju Chung, Mahnaz Asgharnejad, Lars Bauer, et al.
Journal of Biomechanics|March 22, 2006
Determination of trunk muscle forces for flexion and extension by using a validated finite element model of the lumbar spine and measured in vivo dataAntonius Rohlmann, Lars Bauer, Thomas Zander, et al.
Current Medical Research and Opinion|February 21, 2018
Randomized, double-blind, crossover study of the adhesiveness of two formulations of rotigotine transdermal patch in patients with Parkinson's diseaseJan-Peer Elshoff, Lars Bauer, Nadine Goldammer, et al.
Arthritis Research & Therapy|October 30, 2021
Predictors of long-term clinical response in patients with non-radiographic axial spondyloarthritis receiving certolizumab pegolWalter P Maksymowych, Thomas Kumke, Simone E Auteri, et al.
BMC Neurology|June 9, 2016
Evaluation of rotigotine transdermal patch for the treatment of apathy and motor symptoms in Parkinson's diseaseRobert A Hauser, Jaroslaw Slawek, Paolo Barone, et al.
Current Medical Research and Opinion|September 7, 2013
Comparison of the bioavailability and adhesiveness of different rotigotine transdermal patch formulationsJan-Peer Elshoff, Lars Timmermann, Miriam Schmid, et al.
Journal of Parkinson'S Disease|August 29, 2016
Efficacy of Rotigotine at Different Stages of Parkinson's Disease Symptom Severity and Disability: A Post Hoc Analysis According to Baseline Hoehn and Yahr StageNir Giladi, Anthony P Nicholas, Mahnaz Asgharnejad, et al.
Pageof 5

Showing results (1-10 of 47) with videos related to

Sort By:
Pageof 5
BMC Neurology|September 27, 2012
Transdermal rotigotine for the perioperative management of restless legs syndromeBirgit Högl, Wolfgang H Oertel, Erwin Schollmayer, et al.
Journal of Parkinson'S Disease|April 11, 2016
Rotigotine in Combination with the MAO-B Inhibitor Selegiline in Early Parkinson's Disease: A Post Hoc AnalysisNir Giladi, Mahnaz Asgharnejad, Lars Bauer, et al.
Studies in Health Technology and Informatics|October 2, 2004
Realtime textured 3D-models for medical applicationsCarsten Kübler, Lars Bauer, Peter Heinze, et al.
Expert Opinion on Pharmacotherapy|June 21, 2016
Evaluation of rotigotine transdermal patch for the treatment of depressive symptoms in patients with Parkinson's diseaseSun Ju Chung, Mahnaz Asgharnejad, Lars Bauer, et al.
Journal of Biomechanics|March 22, 2006
Determination of trunk muscle forces for flexion and extension by using a validated finite element model of the lumbar spine and measured in vivo dataAntonius Rohlmann, Lars Bauer, Thomas Zander, et al.
Current Medical Research and Opinion|February 21, 2018
Randomized, double-blind, crossover study of the adhesiveness of two formulations of rotigotine transdermal patch in patients with Parkinson's diseaseJan-Peer Elshoff, Lars Bauer, Nadine Goldammer, et al.
Arthritis Research & Therapy|October 30, 2021
Predictors of long-term clinical response in patients with non-radiographic axial spondyloarthritis receiving certolizumab pegolWalter P Maksymowych, Thomas Kumke, Simone E Auteri, et al.
BMC Neurology|June 9, 2016
Evaluation of rotigotine transdermal patch for the treatment of apathy and motor symptoms in Parkinson's diseaseRobert A Hauser, Jaroslaw Slawek, Paolo Barone, et al.
Current Medical Research and Opinion|September 7, 2013
Comparison of the bioavailability and adhesiveness of different rotigotine transdermal patch formulationsJan-Peer Elshoff, Lars Timmermann, Miriam Schmid, et al.
Journal of Parkinson'S Disease|August 29, 2016
Efficacy of Rotigotine at Different Stages of Parkinson's Disease Symptom Severity and Disability: A Post Hoc Analysis According to Baseline Hoehn and Yahr StageNir Giladi, Anthony P Nicholas, Mahnaz Asgharnejad, et al.
Pageof 5